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Background: Sepsis is the leading cause of mortality in critically ill patients. Procalcitonin (PCT) is a promising
marker for identiﬁcation of bacterial sepsis. The aim of this study was to determine the diagnostic accuracy of
serum PCT concentration in patients with suspected sepsis admitted to mixed medical-surgical Intensive care
unit (ICU).
Material and methods: A cross-sectional study conducted at section of Chemical Pathology, Department of
Pathology and Laboratory Medicine and ICU. Patients with suspected sepsis were included, serum PCT cut oﬀ
≥0.5 ng/ml was taken for diagnosing sepsis. Diagnostic accuracy was measured in terms of sensitivity, speciﬁcity, positive predictive value (PPV) and negative predictive value (NPV) taking blood culture as gold standard.
Furthermore, diﬀerent cut oﬀs were compared by using receiver operating characteristic curves (ROC). Data
analysis was done on SPSS version 20.
Results: Median age of the study group (n = 103) was 48 years (IQR: 22), 60% being males. Out of the 103
patients included 82 patients had PCT levels above the optimal cut oﬀ. At a serum PCT cutoﬀ of 0.5 μg/L, the
sensitivity and speciﬁcity for the diagnosis of sepsis was found to be 93.75% and 43.59% respectively. NPV was
higher compared to PPV making PCT a reliable marker to for the screening out of sepsis patients. Furthermore, it
was revealed that PCT having an AUC = 0.70 outperformed WBC (AUC = 0.5) and CRP (AUC = 0.6).
Conclusion: Elevated PCT concentration is a promising indicator of sepsis in newly admitted critically ill patients
capable of complementing clinical signs and routine laboratory parameters.

1. Introduction
The past century has witnessed a rising trend in the incidence of
infections, sepsis, and septic shock regardless of overwhelming development in treatment modalities [1]. Sepsis is a common condition that
exists in patients admitted to intensive care units (ICU). Audits of ICU
worldwide showed that 29.5% patients had sepsis on admission or
during the ICU stay [2]. According to a study undertaken in 150 ICUs
across 16 Asian countries; 28.3% of all admissions in participating units
from Pakistan had sepsis [3].
Microbiological culture testing remains the traditional gold standard diagnostic modality for identiﬁcation of sepsis with its own limitations. Prolong turnaround times for culture and the fact that blood
cultures detect bacteraemia in only about 50% of patients with clinical
suspicion of sepsis pose diagnostic challenge for septic patients in ICU
[4]. Diagnosis is optimised by using biochemical tests for sepsis, such as
C - reactive protein (CRP) or leukocyte count (WBC) which have reportedly low diagnostic accuracy and are at times ambiguous [5].

∗

Search for new markers for providing early diagnosis with improved
sensitivity and speciﬁcity continues. Procalcitonin (PCT) has developed
as an ideal biomarker for sepsis and early detection of bacteraemia as it
can be quantiﬁed and promptly interpreted in light of clinical context to
aid decision making in patient care [6]. PCT has been used as marker of
sepsis with sensitivity and speciﬁcity of 83% and 62% respectively with
signiﬁcantly high levels in the patients having sepsis and positive blood
culture results than with culture negative results [7,8].
PCT is a glycoprotein present in C cells of thyroid gland. It belongs
to the group of related peptide (C-GRP) encoded by the CALC-1 gene
and is formed from the common precursor pre-calcitonin [9]. In healthy
subjects, CALC-1 genes synthesize Calcitonin, but presence of microbial
infection through endotoxin or pro-inﬂammatory cytokines increases
calcitonin gene expression and PCT mRNA is mostly synthesised. This
leads to release of PCT from all parenchymal tissue, exclusively in response to bacterial infection only and not viral or inﬂammatory disease
[10]. This makes PCT to be a speciﬁc diagnostic marker to detect
bacterial sepsis. On the other hand serum levels of PCT increase briskly
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within 2–6 h after the stimulus making it a rapid diagnostic marker
compared to culture [11,12].
As the expression of PCT depends upon the genetic framework of the
population, therefore, it is important to assess its role and utility in
Pakistani population with diﬀerent metabolic and biochemical makeup.
The aim of this study was to determine the diagnostic accuracy of PCT
in diagnosis of bacterial sepsis in critically ill patients admitted at ICU
of Aga Khan University Hospital Karachi (AKUH-K), by taking blood
culture as gold standard.
2. Methods
This interdisciplinary cross sectional study was conducted in the
Section of Chemical Pathology, Department of Pathology & Laboratory
Medicine and mixed medical-surgical ICU of AKUH-K, Pakistan. The
study was approved by the institutional Ethical Review Committee
(1573-Pat-ERC-11). Our study was registered with NIH clinicaltrials.
gov (Unique ID: NCT03506152). The work has been reported in line
with the Strengthening the Reporting of Cohort Studies in Surgery
(STROCSS) criteria [13].
2.1. Inclusion criteria
Adult male and female patients between 18 and 70 years of age with
a clinical suspicion of sepsis as guided by the ICU physicians were recruited through non-probability purposive sampling, within 24 h of ICU
admission during January to December 2014. The criteria of suspected
sepsis was used for labelling the cases included the presence of any two
or more of the following conditions at the time of admission: temperature ≥38 °C or < 36 °C, heart rate > 90 beats/min, respiratory
rate > 20 breaths/min, white blood cell count < 4 × 109/L (< 4000/
mm³), > 12 × 109/L (> 12,000/mm3). Sepsis was further conﬁrmed
by the presence of positive blood culture. Furthermore other markers of
sepsis including CRP levels, WBC counts and blood culture undertaken
at the time of admission as a part of routine care were also recorded.

Fig. 1. Distribution of consort showing critically ill patients included in ﬁnal
analysis with suspected sepsis from medical and surgical ICU.

standard. For further analysis, Receiver operative characteristic (ROC)
curve was plotted for PCT and area under the curve (AUC) calculated.
Furthermore, association between CRP, WBC and PCT was done using
ROC curve and respective AUC were compared.

2.2. Exclusion criteria
Patients above 70 years of age were excluded due to ‘immune senescence’ in elderly giving rise to diﬀerent presentation of bacteraemia.
Furthermore, patients discharged before 24 h, patients who had blood
transfusion before ICU stay and those with organ failure were excluded
from the study.
Data was collected on predesigned forms by the team of primary
investigators. Patients were recruited after informed consent from immediate family members/care takers.
Seven ml of blood was drawn in gel separator tubes within 24 h of
admission in ICU for PCT determination. Blood samples were centrifuged at 3000 rpm and serum was separated and stored at −20 °C
until
assayed.
Serum
PCT
was
measured
by
ElectroChemiluminescence immunoassay (ECLIA) on the Roche Elecsys E170
immunoassay analyser using manufacturer's recommendations. Results
are expressed as micro gram of PCT per litre of serum (ug/L). For internal quality control 2 levels of manufacturer provided controls [low
and high] were run with each batch of analyte while samples from
College of American Pathologists (CAP, USA) were run for external
quality control. PCT levels > 0.5 μg/L are considered positive for diagnosis of sepsis.
A sample size of 103 was calculated by using PASS 11 word home
edition software by taking the sensitivity 83%, speciﬁcity 62%,
Prevalence 37.4% [14] and precision 10%.
Data analysis was done on SPSS version 20. Shapiro Wilk test was
used to check normality of data. As the data that was skewed; median
values were reported along with interquartile ranges (IQR) for quantitative variables. Diagnostic accuracy of PCT was calculated on the basis
of sensitivity, speciﬁcity, PPV and NPV taking blood culture as gold

3. Results
One hundred and three patients met inclusion criteria and were
included in the ﬁnal study analysis as shown in Fig. 1. Sixty percent of
the patients were males (n = 62). The median age of the group was 48
years (IQR: 22) and BMI was 25.4 kg/m2 (IQR: 4.22). Out of the 103,
43.7% were obese and 8.7% were overweight according to Asian BMI
classiﬁcation [15]. Median PCT levels were 1.5 μg/L (IQR: 8.5 μg/L),
79% (n = 82) patients had PCT levels > 0.5 μg/L (median PCT 2.7 μg/
L).
Sixty four patients had bacterial growth on blood culture while 39
samples did not show growth over a period of 5 days. Among the
various organisms identiﬁed on culture Escherichia coli (E.Coli) (n = 21)
and Staphylococcal infections (n = 22) were the most frequent as depicted in Fig. 2.
PCT levels with a median value of 2.14 μg/L in the culture positive
group, were found to be signiﬁcantly higher compared to culture negative group (p value < 0.01). Furthermore, median CRP levels and
median WBC levels were also higher in the culture positive groups as
shown in Table 1. The sensitivity and speciﬁcity for the diagnosis of
sepsis compared to culture as gold standard was found to be 93.75%
(95% CI: 84.76%–98.27%) and 43.59% (95% CI: 27.81%–60.38%) respectively. NPV was calculated to be 80.95% and was higher compared
to PPV (73%) making PCT a better marker for screening of patients with
sepsis.
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Fig. 2. Showing culture results (n = 64).

International Sepsis Deﬁnition Conference [17]. Furthermore, these
ﬁndings were also conﬁrmed by the ICU consultants.
Our study reported a male predominance with sepsis (60%), another
study conducted at our centre undertaken over a period of two years
from 2012 to 2013 has reported that 209 patients admitted to the
surgical ICU had sepsis; with a male predominance of 67.6% which is
correlating with our ﬁndings [18]. Similarly studies from other centres
and a multicentre trial from India also reported higher rates of sepsis
associated with male gender compared to females [19,20].
Additionally, higher WBC counts reported in our study are in
agreement with various studies which have also evaluated the eﬃcacy
of WBC as a marker of sepsis and have reported higher counts in case of
culture proven sepsis [21–23].
Based on data collected by the European Antimicrobial Resistance
Surveillance Network (EARS-Net) and the former EARSS, Escherichia
coli and Staphylococcus aureus are the main causes of bloodstream infections in humans [24]. And our study seconds these ﬁndings.
The PCT cut oﬀ employed by ICUs worldwide for diagnosis of sepsis
greatly varies. At a serum PCT cutoﬀ of 0.5 μg/L, our study has reported
a sensitivity and speciﬁcity of 93.75% and 43.59% respectively. The
diagnostic eﬃcacy of PCT was further tested with receiver operating
characteristic curves compared to culture which revealed an AUC of
0.7. The cut oﬀ that maximizes the area under the curve for sepsis diagnosis is found to be 1.5 μg/L. This cut oﬀ has a better speciﬁcity
compared to a cut oﬀ 0.5 μg/L. Furthermore, this is in concordance with
various published studies. Results summarized in Table 3.
Therefore, we recommend that for diﬀerentiating bacterial sepsis
from other causes of sepsis a cut-oﬀ of 1.5 μg/L should be utilized by
adult ICUs in our population.
There were some limitations of this study; serial measurement of
PCT were not undertaken to report the kinetics and PCT could also be
falsely negative in early course of infection which warrants treatment.
Additionally any localized infections e.g. osteomyelitis, abscess can also
present with PCT values below the cut oﬀ. Antibodies testing for viral
infections were not done; similarly fungal cultures were not performed
to rule out fungal infections. The sample size was small limiting the
power of the present study and there is a likelihood that large scale
studies in Pakistani ICU may diﬀer from our ﬁndings. A small subset of
patients (n = 12) in our study however presented with markedly elevated procalcitonin levels but negative culture results ranging from

Table 1
Comparison of Biomarkers of Sepsis in Culture Positive and Negative Groups in
critically ill patients Admitted in ICU [n = 103].
Biomarker [Reference
Range]

PCT [ < 0.5 μg/L]
CRP [0–5 mg/L]
WBC [4.0-10 × 109/L]
a

Culture positive
group [n = 64]

Culture negative
group [n = 39]

Median [IQR]

Median [IQR]

2.14 [10.21]
98 [125]
14.3 [10.53]

0.8 [3.76]
86 [138]
12.8 [8.2]

p- value

0.001a
0.239
0.314

p value < 0.01 = highly signiﬁcant.

ROC curve analysis was used to compare the performance of PCT
with the other two markers of sepsis recorded for each study participant. PCT having an AUC = 0.7 outperformed WBC (AUC = 0.5) and
CRP (AUC = 0.6). Fig. 3 illustrates the ROC curve results for PCT, WBC
and CRP compared to culture results.
Diagnostic performance of PCT at various cut oﬀs was evaluated.
Performance of PCT at various cut oﬀs is shown in Table 2. PCT cut-oﬀ
of 1.5 μg/L has better speciﬁcity for diagnosing sepsis when compared
to a cut-oﬀ of 0.5 μg/L; at the cost of sensitivity.
4. Discussion
To date no gold standard test has been identiﬁed for diagnosis of
sepsis because culture results may be aﬀected by various pre analytical
issues including pre-treatment with antibiotics and inadequate and inappropriate sampling. Moreover results of microbiological studies are
not immediately available and in most cases the turnaround time exceeds the time line for a swift diagnosis. A biomarker like PCT that
possesses rapid kinetics and has acceptable diagnostic accuracy for
identifying sepsis is needed for laboratories as well as clinicians.
To the best of our knowledge this is the ﬁrst study exploring the
accuracy of PCT for the diagnosis of bacterial sepsis in critically ill adult
patients in ICUs from Pakistan. Most studies from Pakistan aimed at
diagnostic utility of PCT are undertaken in the neonates and children
[5,16]. Our study population was a large, diverse group of critically ill
adult patients with sepsis, admitted to the ICU. Patients were classiﬁed
into having suspected sepsis on the basis of the 1991 ACCP/SCCM
Sepsis Directory and the diagnostic criteria advanced by the 2001
182
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Fig. 3. ROC analysis of PCT, CRP and WBC against culture as gold standard. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the Web version of this article.)
Table 2
Performance of PCT at various cut oﬀs for sepsis diagnosis compared to culture.
PCT
Cut oﬀ [μg/L]

Sensitivity [%]

0.5
1
1.5
2
2.5

93.8
71.9
64
51
51

Table 3
Comparison of diagnostic accuracy of PCT for diagnosis of sepsis with other
studies at a cut oﬀ of 0.5 μg/L and 1.5 μg/L.

Speciﬁcity [%]

Comparison of diagnostic accuracy of PCT for diagnosis of sepsis with other studies at a
cut oﬀ of 0.5 μg/L

43.5
57
70
70
70

.

Aw TC et al
[25]
Bossink et al.
[26]
Luyt et al. [27]
Sudhir et al.
[28]
Alzahrani et al.
[29]
Our study

3.12 to 100 μg/L. Most of the patients in this group presented with
sepsis secondary to respiratory tract infections (RTIs) (n = 8). Blood
cultures are reported to be less accurate predictors of RTIs compared to
sputum culture and might lead to discrepant outcomes [33]. Another
factor to consider in our study setup was the possibility of patients
receiving antibiotic treatment before cultures were obtained, hence
resulting in false-negative culture results. Furthermore one patient in
our study with elevated PCT presented with malarial infection and
negative cultures, which is in concordance with other studies that have
witnessed elevation of PCT in malaria [34,35].
This study demonstrates PCT to be promising marker of sepsis in
critically ill patients. However we recommend that PCT values must be
considered in conjunction with clinical examination and other laboratory tests while implementing the therapeutic plan. Thus to conclude
adding PCT to the list of standard laboratory work up of critically ill
patients with suspected sepsis could increase diagnostic accuracy
leading to improved patient care.

Country

n

Sensitivity [%]

Speciﬁcity [%]

Singapore

626

79.6

47.2

Netherlands

133

65

58

France
India

172
100

72
94

24
Not reported

Saudi Arabia

109

54.4

65.9

Pakistan

103

93.8

43.5

Comparison of diagnostic accuracy of PCT for diagnosis of sepsis with other
studies at a cut oﬀ of 1.5 μg/L
Country
n
Sensitivity
Speciﬁcity [%]
[%]
Du et al. [30]
Wanner et al.
[31]
Tugrul et al.
[32]
Our study

China
Switzerland

51
133

80

74
76

77

Turkey

85

73

80

Pakistan

103

64

70

183

Downloaded for Anonymous User (n/a) at Aga Khan University Hospital from ClinicalKey.com by Elsevier on January 28, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.

Annals of Medicine and Surgery 35 (2018) 180–184

S. Ahmed et al.

Provenance and peer review
[9]

Not commissioned, externally peer reviewed.
Ethical approval

[10]

Study was approved by the institutional Ethical Review Committee
(1573-Pat-ERC-11) of the Aga Khan University.

[11]

[12]

Sources of funding

[13]

The Departmental Resident Research Grant (I.D: RRG # 2013–06),
Department of Pathology and Laboratory Medicine, the Aga Khan
University.

[14]

Author contribution

[15]
[16]

Dr Sibtain Ahmed performed the literature search, data collection
and majority of the writing work in the ﬁrst draft. Dr Aysha Habib Khan
helped in designing the outline and reviewed the ﬁnal draft. Dr Madiha
Hashmi assisted in patient recruitment and contributed in writing the
ﬁrst draft. Dr Lena Jafri, Dr Imran Siddiqui helped in data analysis and
contributed in writing and ﬁnal review of the manuscript. Dr Farooq
Ghani conceived the idea and coordinated the writing of the paper. All
authors have reviewed the ﬁnal draft and agreed upon.

[17]

[18]

[19]

Conﬂicts of interest
[20]

There is no conﬂict of interest associated with any of the authors.
We have had no involvements that might raise the question of bias in
the work reported or in the conclusions.

[21]

[22]

Research registration number
[23]

NCT03506152.
[24]

Guarantor
Dr Aysha Habib Khan.
Associate Professor & Consultant Chemical Pathologist.
Department of Pathology & Laboratory Medicine.
Aga Khan University.
Stadium Road.
Karachi, Pakistan.

[25]

[26]

[27]

References
[28]

[1] L. Magrini, G. Gagliano, F. Travaglino, F. Vetrone, R. Marino, P. Cardelli, et al.,
Comparison between white blood cell count, procalcitonin and C reactive protein as
diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to
emergency department, Clin. Chem. Lab. Med. 52 (10) (2014 Oct) 1465–1472.
[2] J.L. Vincent, J.C. Marshall, S.A. Namendys-Silva, B. Francois, I. Martin-Loeches,
J. Lipman, et al., Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit, Lancet Respir Med 2 (5) (2014 May)
380–386.
[3] J. Phua, Y. Koh, B. Du, Y.Q. Tang, J.V. Divatia, C.C. Tan, et al., Management of
severe sepsis in patients admitted to Asian intensive care units: prospective cohort
study, BMJ 342 (2011 Jun 13) d3245.
[4] M. Previsdomini, M. Gini, B. Cerutti, M. Dolina, A. Perren, Predictors of positive
blood cultures in critically ill patients: a retrospective evaluation, Croat. Med. J. 53
(1) (2012) 30–39.
[5] D.A. Khan, A. Rahman, F.A. Khan, Is procalcitonin better than C-reactive protein for
early diagnosis of bacterial pneumonia in children? J. Clin. Lab. Anal. 24 (1)
(2010) 1–5.
[6] C.Y.T.A. Yap, The use of procalcitonin in clinical practice, Proceedings of Singapore
Healthcare 23 (1) (2014) 33–37.
[7] S. Karlsson, M. Heikkinen, V. PettilÃ¤, S. Alila, S. VÃ¤isÃ¤nen, K. Pulkki, et al.,
Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study, Crit. Care 14 (6) (2010) R205.
[8] M.J. Ruiz-Alvarez, S. GarcÃ-a-Valdecasas, R. De Pablo, M.S. GarcÃ-a, C. Coca,
T.W. Groeneveld, et al., Diagnostic eﬃcacy and prognostic value of serum

[29]

[30]

[31]

[32]

[33]

[34]
[35]

procalcitonin concentration in patients with suspected sepsis, J. Intensive Care Med.
24 (1) (2009) 63–71.
M. Assicot, C. Bohuon, D. Gendrel, J. Raymond, H. Carsin, J. Guilbaud, High serum
procalcitonin concentrations in patients with sepsis and infection, Lancet 341
(8844) (1993) 515–518.
J.H. Kim, J.W. Seo, J.H. Mok, M.H. Kim, W.H. Cho, K. Lee, et al., Usefulness of
plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia, Tuberc. Respir. Dis. 74 (5) (2013) 207–214.
C.A. Tamminga, C.B. Nemeroﬀ, R.D. Blakely, L. Brady, C.S. Carter, K.L. Davis, et al.,
Developing novel treatments for mood disorders: accelerating discovery, Biol.
Psychiatry 52 (6) (2002) 589–609.
S. Jeong, Y. Park, Y. Cho, H.-S. Kim, Diagnostic utilities of procalcitonin and Creactive protein for the prediction of bacteremia determined by blood culture, Clin.
Chim. Acta 413 (21) (2012) 1731–1736.
R.A. Agha, M.R. Borrelli, M. Vella-Baldacchino, R. Thavayogan, D.P. Orgill, The
STROCSS statement: strengthening the reporting of cohort studies in Surgery, Int. J.
Surg. 46 (2017 Oct) 198–202.
J.L. Vincent, Y. Sakr, C.L. Sprung, V.M. Ranieri, K. Reinhart, H. Gerlach, et al.,
Sepsis in European intensive care units: results of the SOAP study, Crit. Care Med.
34 (2) (2006 Feb) 344–353.
P.P. Lai, A.K. Leung, A.N. Li, M. Zhang, Three-dimensional gait analysis of obese
adults, Clin. Biomech. 23 (Suppl 1) (2008) S2–S6.
A.R. Dilshad Ahmad Khan, Farooq Ahmed Khan, Najm-ul-Hassan, Comparison of
serum Procalcitonin and C-reactive protein in diagnosis of Bacterial meningitis,
Pakistan Armed Forces medical Journal. [original] 59 (3) (2009 June 2009).
R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, et al.,
Deﬁnitions for sepsis and organ failure and guidelines for the use of innovative
therapies in sepsis. The ACCP/SCCM consensus conference committee. American
College of chest physicians/society of critical care medicine, Chest Journal 101 (6)
(1992) 1644–1655.
A. Asghar, M. Hashmi, S. Rashid, F.H. Khan, Incidence, outcome and risk factors for
sepsis–a two year retrospective study at surgical intensive care unit of a teaching
hospital in Pakistan, J. Ayub Med. Coll. Abbottabad 28 (1) (2016 Jan-Mar) 79–83.
F.B. Mayr, S. Yende, D.C. Angus, Epidemiology of severe sepsis, Virulence 5 (1)
(2014) 4–11.
S. Todi, Sepsis: new horizons, Indian J. Crit. Care Med.: peer-reviewed 14 (1) (2010)
1 oﬃcial publication of Indian Society of Critical Care Medicine.
D. Zhang, S.T. Micek, M.H. Kollef, Time to appropriate antibiotic therapy is an
independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis*, Crit. Care Med. 43 (10) (2015) 2133–2140.
A. Linder, P. Akesson, M. Inghammar, C.-J. Treutiger, A. LinnÃ©r, J. SundÃ©nCullberg, Elevated plasma levels of heparin-binding protein in intensive care unit
patients with severe sepsis and septic shock, Crit. Care 16 (3) (2012) R90.
A. Nierhaus, S. Klatte, J. Linssen, N.M. Eismann, D. Wichmann, Hedke Jr.et al.,
Revisiting the white blood cell count: immature granulocytes count as a diagnostic
marker to discriminate between SIRS and sepsis-a prospective, observational study,
BMC Immunol. 14 (1) (2013) 8.
C. Gagliotti, A. Balode, F. Baquero, J. Degener, H. Grundmann, D. Gur, et al.,
Escherichia coli and Staphylococcus aureus: Bad News and Good News from the
European Antimicrobial Resistance Surveillance Network, EARS-Net, formerly
EARSS), 2011 2002 to 2009.
T.C.Y.C. Aw, L.S. Yew, W.R. Lim, P.Q. Leow, S.R. Tan, The use of a new rapid
procalcitonin for the evaluation of patients with infection, Clinical Chemistry.
[absrtact] 55 (06) (2009 01 June) A150–A.
A.W.J. Bossink, A.B.J. Groeneveld, L.G. Thijs, Prediction of microbial infection and
mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-Î ± 1-antitrypsin, and lactoferrin compared with clinical variables, Clin. Infect.
Dis. 29 (2) (1999) 398–407.
C.-E. Luyt, A. Combes, C. Reynaud, G. Hekimian, A. Nieszkowska, M. Tonnellier,
et al., Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia, Intensive Care Med. 34 (8) (2008) 1434–1440.
U. Sudhir, R.K. Venkatachalaiah, T.A. Kumar, M.Y. Rao, P. Kempegowda,
Signiﬁcance of serum procalcitonin in sepsis, Indian J. Crit. Care Med.: peer-reviewed 15 (1) (2011) 1 oﬃcial publication of Indian Society of Critical Care
Medicine.
A.J. Alzahrani, Rapid detection of procalcitonin as an early marker of sepsis in
intensive care unit in a tertiary hospital, Int. J. Med. Med. Sci. 1 (11) (2009)
516–522.
B. Du, J. Pan, D. Chen, Y. Li, Serum procalcitonin and interleukin-6 levels may help
to diﬀerentiate systemic inﬂammatory response of infectious and non-infectious
origin, Chinese Med J 116 (4) (2003) 538–542.
G.A. Wanner, M. Keel, U. Steckholzer, W. Beier, R. Stocker, W. Ertel, Relationship
between procalcitonin plasma levels and severity of injury, sepsis, organ failure,
and mortality in injured patients, Crit. Care Med. 28 (4) (2000) 950–957.
S. Tugrul, F. Esen, S. Celebi, P.E. Ozcan, Reliability of procalcitonin as a severity
marker in critically ill patients with inﬂammatory response, Anaesth. Intensive Care
30 (6) (2002) 747.
Y. Zhu, Y. Yuan, H. Huang, Comparison of serum procalcitonin in respiratory infections and bloodstream infections, Int. J. Clin. Exp. Med. 8 (11) (2015)
21586–21592.
C. Manegold, S. Schmiedel, C.B. Chiwakata, M. Dietrich, Procalcitonin serum levels
in tertian malaria, Malar. J. 2 (1) (2003) 34.
D.A. Hesselink, J.-S. Burgerhart, H. Bosmans-Timmerarends, P. Petit, P.J. van
Genderen, Procalcitonin as a biomarker for severe Plasmodium falciparum disease:
a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers
with imported malaria, Malar. J. 8 (1) (2009) 206.

184

Downloaded for Anonymous User (n/a) at Aga Khan University Hospital from ClinicalKey.com by Elsevier on January 28, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.

